AzTrials
AzTrials

Autism Spectrum DisorderNCT01263756

Autism Spectrum Disorders (ASD) Driving Study

An observational study of Autism Spectrum Disorder, run by Massachusetts General Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The proposed pilot study will begin to assess whether driving impairments are included in the functional deficits associated with Autism Spectrum Disorders (ASDs). This will be completed by obtaining data on velocity, collision risk, and visual attention of subjects with ASDs who drive in a simulator. Read more about this study

Who is it for?
Ages 16 to 50 years
Conditions the study is for
Autism Spectrum Disorder
How many people
10 participants
Where
1 siteUnited States
Study dates
Mar 2010to Mar 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 50 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Adolescents and adults, ages 16-50, with Autism Spectrum Disorders.

Who may be able to join

  • Male and female patients, aged 16-50 years
  • Identification as having ASD from a prior diagnosis or participation in community conferences for individuals with ASD

Who cannot join

  • Major sensorimotor handicaps (e.g. deafness, blindness)
  • Inadequate command of the English language
  • Individuals who have never held a valid driver's license
  • Mental retardation (IQ < 80)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Massachusetts General Hospital

    Cambridge, Massachusetts, 02138

Other trials in United States

About this study

Official title: A Study of the Driving Performance of Individuals With Autism Spectrum Disorders

The proposed pilot study will begin to assess whether driving impairments are included in the functional deficits associated with Autism Spectrum Disorders (ASDs). This will be completed by obtaining data on velocity, collision risk, and visual attention of subjects with ASDs who drive in a simulator. The study includes 2-3 visits for the screening period (approximately 6 hours of assessments) and one driving simulation visit (approximately 2.5 hours). The investigators expect to enroll 20 adolescents and adults (ages 16-50, inclusive) who have been identified as having an ASD from a prior diagnosis or participation in community conferences for individuals with ASDs.

Keywords
Driving, Autism Spectrum Disorders, ASD, Attention Deficits, Adults, Adolescents, Pervasive Developmental Disorders
Medical subject headings
Autism Spectrum Disorder, Attention Deficit Disorder with Hyperactivity, Child Development Disorders, Pervasive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01263756
Study groupRoleWhat they receive
ASD groupAdolescents and adults with Autism Spectrum Disorders (ASDs).

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Simulated driving performance of adolescents and adults with ASDs.

    Data will be obtained on velocity, collision risk, and visual attention of subjects with ASDs who drive in the driving simulator at the Massachusetts Institute of Technology (MIT).

    Measured: one-time observation (3 hour assessment)

Secondary outcomes (1)
  1. Questionnaire measures of driving history and behavior of adolescents and adults with ASDs.

    Subjects with ASD will complete two questionnaires, the Driver Behavior Questionnaire and the Driving History Questionnaire, to provide data on the frequency of violations, errors, accidents, and other aspects of driving history and behavior.

    Measured: one-time assessment (2-6 hour screening visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Dec 2010 (estimated)
  2. Study startMar 2010
  3. Primary completionMar 2011
  4. Study completionMar 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01263756
Sponsor's protocol ID
2010-P-000173
Status last verified
Dec 2011
First submitted
29 Nov 2010
Last updated
8 Dec 2011
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Autism Spectrum Disorder, run by Massachusetts General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Simulated driving performance of adolescents and adults with ASDs. (time frame: one-time observation (3 hour assessment)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2011.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in